🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

PTN PTN

Company Profile ↓
$7.94
-6.59% 1Y
Mkt Cap$7.38M
P/E-0.25
P/B-1.55
52W High$28.00
52W Low$5.45
Book Value$-5.14
EPS (TTM)$-32.15

Company Overview

PTN (PTN) is a publicly traded company listed on with a market capitalization of $7.38M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.03.

Recent Developments

  • Trailing 12 Months Year-on-year growth — revenue -100.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-
1 Year:-100.00%

Stock Price Performance

1 Year:-6.59%
6 Months:-54.24%
3 Months:-60.30%
1 Month:-27.75%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 11% of range
$5.45 $28.00
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)36.63 · Neutral
Price Performance
1M-27.75%
3M-60.30%
6M-54.24%
1Y-6.59%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Trading 71.6% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.25
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-5.14
Price to Book
-1.55
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-
Profit 5Y
-
Revenue (YoY)
-100.00%
Earnings (YoY)
-

Profitability & Returns

ROCE
-
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
Gross Margin
-
EPS (Latest Qtr)
$-0.37
EPS (TTM)
$-32.15

Balance Sheet & Liquidity

Debt/Equity
0.03
Quick Ratio
0.36
Current Ratio
0.36
Debt
$163.78K
Total Assets
$13.23M
Current Assets
$12.79M
Working Capital
$-5.09M

Ownership

Promoter Holding
7.86%
Chg in Prom Hold
0.00%
FII / Inst Holding
55.72%
Chg in FII Hold
0.00%

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$0
EBITDA
$-17.03M
Free Cash Flow
$-21.31M
Operating Cash Flow
$-21.31M
Shares Outstanding
929.60K
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Sep 2021Dec 2021Mar 2022Sep 2022Dec 2022Mar 2023Sep 2023Dec 2023Mar 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -----------------------------------008.85M116.04K3.92M
Cost of Revenue ----------------------------------000---
Gross Profit ----------------------------------000---
Operating Expenses -----------------------------------5.23M4.60M4.19M7.44M5.50M
Operating Income --11.80M-12.63M-12.09M--12.44M-9.44M-3.01M-11.23M2.94M-517.44K--5.63M-5.05M-5.76M--4.86M-5.64M-5.71M--3.95M-9.25M-6.49M-7.22M-8.45M-7.82M-8.75M-5.59M-7.30M-6.11M1.17M-9.22M-7.76M--5.23M-4.60M4.66M-7.33M-1.58M
EBITDA ------------------------------------4.76M-2.17M4.69M-7.25M-1.41M
Interest Expense -----------------------------------1.79K3.49K2.00K4981.27K
Pretax Income ------------------------------------4.81M-2.23M4.68M-7.26M-1.43M
Tax Provision ----------------------------------------
Net Income -12.09K-12.41K-13.25K-12.70K-13.36K-13.05K-10.03K-3.56K13.31K10.60K3.03K-73911.81K-5.68M-5.04M-5.73M52.22M-4.50M-5.24M-5.38M-7.30M-3.94M-9.99M-5.73M-7.11M-8.69M-7.63M-8.26M2.71M-8.67M-5.21M-7.84M-8.44M-7.82M--4.81M-2.23M4.68M-7.26M-1.43M
Diluted EPS -0.09-0.08-0.08---0.08-0.06-0.020.070.050.010.000.06-0.03-0.02-0.030.23-0.02-0.02-0.02-0.03------------0.53-19.71-5.92-9.13-4.26-2.86-0.37
R&D Expense -10.60M11.27M10.68M-11.23M8.13M9.06M-14.16M6.05M7.07M-3.62M2.96M3.94M-3.13M3.26M3.64M-2.92M4.01M2.51M3.48M5.43M4.98M6.03M4.37M4.83M5.01M5.55M7.16M5.74M3.43M3.76M-2.53M4.32M3.52M

Profit & Loss (Annual)

Figures in USD.

Metric Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Revenue 14.18M1.48M73.74K10.36K--067.13M67.13M60.30M117.99K-188.60K1.47M4.85M4.49M0
Cost of Revenue ------------217.53K418.47K97.64K0
Gross Profit ------------1.25M4.44M4.39M0
Operating Expenses ------------37.84M37.92M34.67M22.71M
Operating Income -3.01M-13.65M-18.79M-15.59M-15.79M-17.29M-49.25M25.93M25.93M35.74M-23.61M-33.38M-36.59M-33.49M-30.28M-22.71M
EBITDA -------------36.04M-28.40M-29.38M-17.03M
Interest Expense ------------29.68K20.01K17.11K15.03K
Pretax Income -------------36.20M-28.71M-29.74M-17.31M
Tax Provision ------------0-4.67M0-
Net Income -1.79M-12.82M-17.25M-20.86M-13.93M-17.67M-51.71M24.70M24.70M35.77M-22.43M-33.60M-36.20M-24.04M-29.74M-17.31M
Diluted EPS -------0.330.120.120.16-0.10--189.50-110.50-101.16-32.15
R&D Expense 12.29M10.38M13.81M10.53M10.83M24.56M43.07M32.57M32.57M14.86M13.96M12.93M21.33M22.63M22.40M14.90M

Balance Sheet (Annual)

Figures in USD.

Metric Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Total Assets --21.17M5.38M25.07M12.56M29.47M10.86M56.83M39.02M104.74M85.05M67.30M36.07M17.94M10.74M3.27M
Current Assets -------------34.60M16.32M9.77M2.92M
Cash & Equivalents 4.38M5.41M18.87M3.83M19.17M12.18M27.30M8.00M40.20M38.00M43.51M82.85M60.10M29.94M7.99M9.53M2.56M
Inventory -------------944.47K526.00K0-
Receivables -------------1.78M2.92M0-
Total Liabilities --2.98M3.55M2.10M2.77M17.27M28.44M62.00M12.05M4.19M4.88M17.65M19.80M19.92M10.85M8.04M
Current Liabilities --2.81M3.46M2.06M2.77M7.36M13.88M54.96M10.76M4.19M3.93M10.51M16.26M15.13M9.66M8.01M
Long Term Debt -----09.78M14.11M6.28M332.90K332.90K------
Total Debt -------------1.15M1.05M590.34K163.78K
Total Equity 3.31M9.32M18.19M1.83M22.98M9.79M12.20M-17.59M-5.16M26.96M100.55M80.17M49.65M16.27M-1.98M-111.50K-4.78M
Shares Outstanding -------------185.42K233.13K358.53K929.60K

Cash Flows (Annual)

Figures in USD.

Metric Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Operating Cash Flow -5.73M-11.03M-15.49M-13.65M-12.21M-13.36M-47.36M12.88M1.70M-21.78M41.33M-93.64K-29.92M-29.27M-31.46M-21.31M
Investing Cash Flow 38.01K3.45M479.38K-5.30M5.24M0-1.40M991.60K227.55K-36.14K-62.88K-5.72K-261.37K-3.43M12.45M3.13M
Financing Cash Flow 6.72M21.05M-34.92K34.29M-18.79K28.47M29.47M18.32M-4.13M27.33M-1.92M-22.65M18.36K10.75M20.55M11.21M
Capital Expenditure -7.00K--0-59.61K-6.24K-0-17.70K-133.40K-22.45K-36.14K-62.88K-5.72K-261.37K-433.93K-42.53K-
Free Cash Flow -5.74M--15.49M-13.71M-12.21M-13.36M-47.38M12.75M1.68M-21.82M41.26M-99.36K-30.18M-29.71M-31.50M-21.31M
Net Change in Cash -------------30.17M-21.95M1.54M-6.96M

Ratios (Annual)

Figures in %.

Metric Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Gross Margin % ------------85.2%91.4%97.8%-
Operating Margin % -21.3%-925.4%-25,476.5%-150,421.4%---38.6%38.6%59.3%-20,007.6%17,701.3%-2,491.6%-689.9%-674.3%-
Net Margin % -12.6%-868.6%-23,398.6%-201,352.9%---36.8%36.8%59.3%-19,006.9%17,813.9%-2,465.1%-495.2%-662.3%-
ROE % -19.2%-70.4%-942.3%-90.8%-142.3%-144.7%294.1%-478.3%91.6%35.6%-28.0%-67.7%-222.5%1,214.1%26,669.9%362.3%
ROCE % --74.3%-976.6%-67.7%-161.3%-78.2%1,627.6%1,385.7%91.8%35.5%-29.1%-58.8%-184.7%-1,192.7%-2,791.7%478.8%

Shareholding Pattern

Insiders
7.86%
Institutions
55.72%
Public Float
60.47%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for PTN

Yahoo Finance Mon, 18 May 2026

Palatin to Begin Trading on Nasdaq Stock Exchange

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company focused on the discovery and development of novel therapeutics targeting the melanocortin receptor system, today announced that its common stock has been approved …

Yahoo Finance hu, 14 May 2026

Palatin Technologies, Inc. Q3 2026 Earnings Call Summary

Moby summary of Palatin Technologies, Inc.'s Q3 2026 earnings call

Yahoo Finance Wed, 13 May 2026

Palatin Technologies Inc (PTN) Q3 2026 Earnings Call Highlights: Strategic Advances Amidst ...

Palatin Technologies Inc (PTN) reports significant revenue growth and strategic partnerships, while navigating increased expenses and development delays.

Yahoo Finance Wed, 13 May 2026

Transcript: Palatin Techs Q3 2026 Earnings Conference Call

Palatin Techs (AMEX:PTN) held its third-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www…

Yahoo Finance Wed, 13 May 2026

Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing medicines that target the melanocortin receptor (MCR) system, today announced financial results for its fiscal third quarter ended March 31, 2026, and p…

Yahoo Finance Wed, 18 Feb 2026

Palatin Technologies, Inc. Q2 2026 Earnings Call Summary

Moby summary of Palatin Technologies, Inc.'s Q2 2026 earnings call

PTN — Frequently Asked Questions

What is the current share price of PTN?

As of 2026-08-05 17:25 PDT, PTN trades at $7.94 on NASDAQ/NYSE. Its 52-week range is $5.45 to $28.00.

What is the market capitalisation of PTN?

PTN has a market capitalisation of $7.38M on NASDAQ/NYSE.

What is the P/E ratio of PTN?

PTN trades at a trailing price-to-earnings (P/E) ratio of -0.25. Its price-to-book (P/B) ratio is -1.55.

Is PTN a good stock to buy?

This page provides a data-driven analysis of PTN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space